Dosing should be discussed with a qualified healthcare professional rather than adjusted independently
- 2
To the best of our knowledge, neither clinical trials assessing ferroptosis inhibitors in COVID-19 related PD nor any indication of the ferroptosis signature in the brain tissues of COVID-19 patients exist
So even water is not without its risks
Finally, we discuss safety considerations and recommendations, with a focus on U.S
However, one hypothesis, supported by a research group is that following infection by SARS-CoV-2, somehow the microglia become immunoreactive, and destroy more synapses than normal.Covid19 seems to have a high affinity for the brain 3 4 , however this may not be exclusive to covid and may explain the onset of chronic fatigue and depression, among others, which are triggered by other infectious agents